GNRH1 and prostate carcinoma: We will review diverse experiments using cell lines from breast, ovary, endometrium, and prostatic cancers, which have shown that GnRH analogs produce anti-tumoral effects, mainly reducing cell proliferation, tumoral size, and metastasis in vitro and in vivo.